性别影响 Duchenne 心肌病 mdx 模型中的心脏功能。
Gender influences cardiac function in the mdx model of Duchenne cardiomyopathy.
机构信息
Department of Molecular Microbiology and Immunology, School of Medicine, 1 Hospital Drive, Columbia, Missouri 65212, USA.
出版信息
Muscle Nerve. 2010 Oct;42(4):600-3. doi: 10.1002/mus.21763.
Abstract
Aged mdx mice represent an important model for studying Duchenne cardiomyopathy. Herein we compared the cardiac phenotypes of 22-month-old male and female mdx mice. Surprisingly, only females displayed the characteristic cardiac dilation on pressure-volume loop analysis. Female mdx mice also exhibited lower contractility, larger Q waves, and higher ratios of heart weight to body weight. Our results reveal significant gender disparity in mdx cardiac function. Gender should be considered when using the mdx model for the study of Duchenne cardiomyopathy.
摘要
老年 mdx 小鼠是研究杜氏肌营养不良性心肌病的重要模型。在此，我们比较了 22 月龄雄性和雌性 mdx 小鼠的心脏表型。令人惊讶的是，只有雌性在压力-容积环分析中表现出特征性的心脏扩张。雌性 mdx 小鼠还表现出较低的收缩力、较大的 Q 波和更高的心脏重量与体重比。我们的研究结果揭示了 mdx 心脏功能的显著性别差异。在使用 mdx 模型研究杜氏肌营养不良性心肌病时，应考虑性别因素。
相似文献
1
Gender influences cardiac function in the mdx model of Duchenne cardiomyopathy.
Muscle Nerve. 2010 Oct;42(4):600-3. doi: 10.1002/mus.21763.
2
Early manifestation of alteration in cardiac function in dystrophin deficient mdx mouse using 3D CMR tagging.
J Cardiovasc Magn Reson. 2009 Oct 22;11(1):40. doi: 10.1186/1532-429X-11-40.
3
Intracellular calcium handling in ventricular myocytes from mdx mice.
Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H846-55. doi: 10.1152/ajpheart.00688.2006. Epub 2006 Sep 29.
4
Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy.
Hum Mol Genet. 2013 Jul 1;22(13):2634-41. doi: 10.1093/hmg/ddt112. Epub 2013 Mar 3.
5
Membrane sealant Poloxamer P188 protects against isoproterenol induced cardiomyopathy in dystrophin deficient mice.
BMC Cardiovasc Disord. 2011 May 16;11:20. doi: 10.1186/1471-2261-11-20.
6
Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
Stem Cells Transl Med. 2013 Jan;2(1):68-80. doi: 10.5966/sctm.2012-0107. Epub 2012 Dec 27.
7
Functional cardiac consequences of β-adrenergic stress-induced injury in a model of Duchenne muscular dystrophy.
Dis Model Mech. 2024 Oct 1;17(10). doi: 10.1242/dmm.050852. Epub 2024 Oct 9.
8
Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.
Stem Cell Rev Rep. 2019 Dec;15(6):827-841. doi: 10.1007/s12015-019-09916-0.
9
Sarcolipin haploinsufficiency prevents dystrophic cardiomyopathy in mice.
Am J Physiol Heart Circ Physiol. 2021 Jan 1;320(1):H200-H210. doi: 10.1152/ajpheart.00601.2020. Epub 2020 Nov 20.
10
Cardiac electrophysiological characteristics of the mdx ( 5cv ) mouse model of Duchenne muscular dystrophy.
J Interv Card Electrophysiol. 2007 Nov;20(1-2):1-7. doi: 10.1007/s10840-007-9168-z. Epub 2007 Oct 17.
引用本文的文献
1
Cardiac Cell and Animal Models for Duchenne Muscular Dystrophy in the Era of Gene Therapy and Precision Medicine.
Cells. 2025 Aug 27;14(17):1326. doi: 10.3390/cells14171326.
2
DWORF expression is reduced in a large animal model of Duchenne muscular dystrophy.
Dis Model Mech. 2025 Jun 1;18(6). doi: 10.1242/dmm.052285. Epub 2025 Jun 25.
3
Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response.
Cells. 2024 Jul 9;13(14):1168. doi: 10.3390/cells13141168.
4
Cardioprotective Effects of Hydrogen Sulfide and Its Potential Therapeutic Implications in the Amelioration of Duchenne Muscular Dystrophy Cardiomyopathy.
Cells. 2024 Jan 15;13(2):158. doi: 10.3390/cells13020158.
5
Considering impact of age and sex on cardiac cytoskeletal components.
Am J Physiol Heart Circ Physiol. 2024 Mar 1;326(3):H470-H478. doi: 10.1152/ajpheart.00619.2023. Epub 2023 Dec 22.
6
Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients' Induced Pluripotent Stem-Cell-Derived Cardiomyocytes.
Int J Mol Sci. 2023 May 12;24(10):8657. doi: 10.3390/ijms24108657.
7
Evaluation of Cardiac Function in Young Mdx Mice Using MRI with Feature Tracking and Self-Gated Magnetic Resonance Cine Imaging.
Diagnostics (Basel). 2023 Apr 19;13(8):1472. doi: 10.3390/diagnostics13081472.
8
Dwarf Open Reading Frame (DWORF) Gene Therapy Ameliorated Duchenne Muscular Dystrophy Cardiomyopathy in Aged mdx Mice.
J Am Heart Assoc. 2023 Feb 7;12(3):e027480. doi: 10.1161/JAHA.122.027480. Epub 2023 Jan 25.
9
Lifelong Outcomes of Systemic Adeno-Associated Virus Micro-Dystrophin Gene Therapy in a Murine Duchenne Muscular Dystrophy Model.
Hum Gene Ther. 2023 May;34(9-10):449-458. doi: 10.1089/hum.2022.181. Epub 2023 May 2.
10
Tamoxifen treatment ameliorates contractile dysfunction of Duchenne muscular dystrophy stem cell-derived cardiomyocytes on bioengineered substrates.
NPJ Regen Med. 2022 Mar 18;7(1):19. doi: 10.1038/s41536-022-00214-x.
本文引用的文献
1
Contrasting effects of steroids and angiotensin-converting-enzyme inhibitors in a mouse model of dystrophin-deficient cardiomyopathy.
Eur J Heart Fail. 2009 May;11(5):463-71. doi: 10.1093/eurjhf/hfp028. Epub 2009 Feb 20.
2
Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice.
Mol Ther. 2009 Feb;17(2):253-61. doi: 10.1038/mt.2008.264. Epub 2008 Dec 9.
3
Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice.
Hum Gene Ther. 2008 Aug;19(8):851-6. doi: 10.1089/hum.2008.058.
4
Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy.
Neurobiol Dis. 2008 Jul;31(1):1-19. doi: 10.1016/j.nbd.2008.03.008. Epub 2008 Apr 9.
5
The effects of biological sex and diet on the development of heart failure.
Circulation. 2007 Dec 4;116(23):2747-59. doi: 10.1161/CIRCULATIONAHA.106.672006.
6
Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression.
Circ Res. 2008 Jan 4;102(1):121-30. doi: 10.1161/CIRCRESAHA.107.162982. Epub 2007 Oct 25.
7
Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure.
Mol Ther. 2007 Jun;15(6):1086-92. doi: 10.1038/sj.mt.6300144. Epub 2007 Apr 17.
8
Sex and the cardiovascular system: the intriguing tale of how women and men regulate cardiovascular function differently.
Adv Physiol Educ. 2007 Mar;31(1):17-22. doi: 10.1152/advan.00099.2006.
9
New approaches in the therapy of cardiomyopathy in muscular dystrophy.
Annu Rev Med. 2007;58:75-88. doi: 10.1146/annurev.med.58.011706.144703.
10
Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy.
Hum Mol Genet. 2006 Oct 15;15 Spec No 2(SPEC):R253-61. doi: 10.1093/hmg/ddl180.
Zotero 插件